Organisation › Details

Qiagen (Group)

http://www.qiagen.com

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing, and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digeneHPV Test, which is regarded as a "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics. QIAGEN employs more than 3,400 people in over 30 locations worldwide. *

	Start	1985-01-01 established
	Industry	sample preparation (service)
	Industry 2	molecular diagnostics

	Region	Hilden
	Country	Germany
	Street	1 Qiagen Str.
	City	40724 Hilden
	Tel	+49-2103-29-0
	Fax	+49-2103-2922-000
		Address record changed: 2010-10-09

Basic data	Employees	F: 1,001 to 5,000 (2011-12-31)
	Currency	USD
	Annual sales	1,169,747,000 (net sales, consolidated (2011) 2011-12-31)
	Profit	94,949,000 (2011-12-31)
	Cash	221,133,000 (2011-12-31)

		* Document for »About Section«: Qiagen N.V.. (1/11/10). "Press Release: Qiagen and WuXi AppTec Enter into Partnership Agreement for Molecular Biomarker Development". Shanghai.

		Record changed: 2012-04-07

Follow Us!

Top News

Upcoming Events

Associations

Partners

Qiagen (Group)

More documents for Qiagen (Group)